Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genome Diagnostics Laboratory, |
RCV002294710 | SCV002587668 | uncertain significance | Atypical hemolytic-uremic syndrome | 2020-04-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003542351 | SCV004247488 | uncertain significance | not provided | 2023-01-27 | criteria provided, single submitter | clinical testing | Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 1712455). This variant has not been reported in the literature in individuals affected with C3-related conditions. This variant is present in population databases (rs545213448, gnomAD 0.01%). This sequence change falls in intron 11 of the C3 gene. It does not directly change the encoded amino acid sequence of the C3 protein. It affects a nucleotide within the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |